RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth

Oncogene. 2009 Apr 16;28(15):1782-91. doi: 10.1038/onc.2009.16. Epub 2009 Mar 2.

Abstract

Ribonuclease L (RNase L) is an intracellular enzyme that is vital in innate immunity, but also is a tumor suppressor candidate. Here, we show that overexpression of RNase L decreases cellular growth and downmodulates the RNA-binding protein, HuR, a regulator of cell-cycle progression and tumorigenesis. The effect is temporal, occurring in specific cell-cycle phases and correlated with the cytoplasmic localization of RNase L. Both cellular growth and HuR were increased in RNASEL-null mouse fibroblast lines when compared to wild-type cells. Moreover, the stability of HuR mRNA was enhanced in RNASEL-null cells. The HuR 3' untranslated region (UTR), which harbors U-rich and adenylate-uridylate-rich elements, was potently responsive to RNase L when compared to control 3' UTR. Our results may offer a new explanation to the tumor suppressor function of RNase L.

MeSH terms

  • 3' Untranslated Regions / physiology
  • Animals
  • Antigens, Surface / genetics
  • Cell Cycle
  • Cell Proliferation
  • Down-Regulation
  • ELAV Proteins
  • ELAV-Like Protein 1
  • Endoribonucleases / physiology*
  • HeLa Cells
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • RNA, Messenger / analysis
  • RNA-Binding Proteins / antagonists & inhibitors*
  • RNA-Binding Proteins / genetics

Substances

  • 3' Untranslated Regions
  • Antigens, Surface
  • ELAV Proteins
  • ELAV-Like Protein 1
  • ELAVL1 protein, human
  • RNA, Messenger
  • RNA-Binding Proteins
  • Endoribonucleases
  • 2-5A-dependent ribonuclease